How Does Nanotechnology Enhance Monoclonal Antibodies?
Nanotechnology plays a crucial role in enhancing the effectiveness and delivery of monoclonal antibodies. By integrating mAbs with nanoparticles, we can improve their targeting precision, reduce side effects, and enhance their therapeutic efficacy. Nanoparticles can be engineered to carry multiple mAbs, enabling simultaneous targeting of different antigens.